News 4 June 2026 - 5 June 2026

Etihad Orders 10 Boeing Jets, Raising Talk of Hard-to-Get 787 Slots

Stock Market Today: Live Updates 12.07.2026

LIVEMarkets rolling coverageStarted: July 12, 2026, 4:00 AM EDTUpdated: July 13, 2026, 1:33 AM EDT Xero, Two ASX Software Names Trade Under DCF Value as Cash Flow Draw July 13, 2026, 1:33 AM EDT. Investors looking for steady cash generators in a choppy market are turning to ASX-listed stocks trading below discounted cash flow estimates. Xero (ASX:XRO), the cloud accounting outfit out of Wellington with a A$12.52 billion market cap, pulls NZ$2.75 billion in subscriber sales but is seeing its margins squeezed and leans on outside borrowing. The company’s push into AI and new partners is meant to give better
July 12, 2026
FDA Letter Puts Pressure on Medline After IPO Drop

FDA Letter Puts Pressure on Medline After IPO Drop

Medline Inc. MDLN got hit with another warning letter from U.S. regulators Friday, the second warning in as many months. The back-to-back warnings put more heat on Medline’s quality control, just weeks after its IPO. The stock ended Thursday at $34.45, flat. Latest quote showed a 0.06% dip from the close. Medline’s timing is under a microscope. The firm listed on Nasdaq in December with 2025’s biggest IPO. Now, investors are watching to see if Medline’s hospital supply operation is large enough to weather regulatory noise, tariffs, and post-IPO selling. The stock is trading above the $29 IPO price but still distant from its $41 first-day close.
June 5, 2026
9F Stock Is Quiet Near $3 — But a HK$101 Million Loan Filing Puts Cash Timing in Play

9F Stock Is Quiet Near $3 — But a HK$101 Million Loan Filing Puts Cash Timing in Play

9F Inc.’s Nasdaq-listed American depositary shares were quoted near $3 early Friday, leaving the small Chinese fintech name in a narrow tape before the regular U.S. session opened. The stock quote on 9F’s investor site showed the ADSs at $3.01, down 1.77%, with volume of just 407 shares and a market value of about $35.4 million. The 52-week range was wide, from $1.25 to $9.48, a reminder that thinly traded micro-cap stocks — companies with small market values — can move hard on little volume.
June 5, 2026
Inseego up 1.4% Thursday, putting Nokia bet in the spotlight

Inseego up 1.4% Thursday, putting Nokia bet in the spotlight

Inseego Corp. shares finished up 19 cents at $14.01 on Thursday. The wireless equipment maker, traded on Nasdaq, took a market cap around $229 million into Friday’s pre-market session. A small after-hours move put the quote at $14.02, with little volume, according to MarketWatch. Inseego’s gain was small. Attention now turns away from daily price shifts to the company’s pending deal with Nokia and the scale it might finally deliver to investors.
June 5, 2026
Vinci Compass heads toward June payout with shares under pressure

Vinci Compass heads toward June payout with shares under pressure

Vinci Compass Investments Ltd. heads into U.S. trading Friday with the stock’s latest quote holding up, as new insider-sale filings come out and investors look to a dividend set for payment next week. The Latin American asset manager, which trades on the Nasdaq, was last seen at $9.86, up $0.13 on the day, market data showed. Wall Street financials supported the wider market Thursday while the Nasdaq Composite edged down 0.09%.
June 5, 2026
UK & AU Stock Market Today: Live Updates 05.06.2026

UK & AU Stock Market Today: Live Updates 05.06.2026

LIVEMarkets rolling coverageStarted: June 5, 2026, 4:00 AM EDTUpdated: June 6, 2026, 3:57 AM EDT 6 Key Financial Metrics to Evaluate Aristocrat Leisure Ltd (ASX:ALL) Shares June 6, 2026, 3:57 AM EDT. The Aristocrat Leisure Ltd (ASX:ALL) share price has declined 10.33% year-to-date. Key metrics shaping its performance include $6.6 billion annual revenue with an 11.7% three-year compound annual growth rate (CAGR), a gross margin of 58.6% indicating solid operational profitability, and a profit of $1.3 billion, growing at a 16.7% CAGR. Financial health metrics highlight a net debt level of $1.45 billion and a leverage ratio (debt/equity) of 38.3%,
June 5, 2026
Zillow Shares Edge Up as Housing Data Raises Caution

Zillow Shares Edge Up as Housing Data Raises Caution

Zillow Group shares saw modest gains late Thursday. The more heavily traded Class C shares changed hands at $35.92, up 1.2%. Class A shares traded at $35.98, up 1.1%. Investors looked at new data signaling the U.S. housing rebound is still uneven. Volume for Class C stock approached 5 million, while Class A shares saw roughly 1.3 million traded. Nasdaq’s main session was closed at the dateline. June 4 wasn’t on the exchange’s 2026 holiday calendar, and regular hours are 9:30 a.m. to 4:00 p.m. Eastern, with after-hours from 4 p.m. to 8 p.m.
June 5, 2026
Old National Bancorp Stock Jumps as Bank Shares Bounce

Old National Bancorp Stock Jumps as Bank Shares Bounce

Old National Bancorp shares climbed almost 3% on Thursday as investors turned back to financials in a wider bank stock rally. The Nasdaq-traded stock was recently quoted at $23.97, up 66.5 cents. It traded in a range of $23.43 to $24.07. The market cap was around $9.3 billion, and the P/E ratio stood at 12.4. That put the stock at about 12.4 times annual earnings. Financial stocks carried most of the gains as the U.S. session turned out mixed. The Dow ended up 1.73% at an all-time high, the S&P 500 rose 0.41%, and the Nasdaq lost 0.09%. Reuters reported financials as one of the top S&P 500 sectors. Paul Nolte at Murphy & Sylvest told Reuters that investors were
June 5, 2026
LeMaitre Vascular Shares Rise as Medical-Device Names Gain

LeMaitre Vascular Shares Rise as Medical-Device Names Gain

LeMaitre Vascular shares gained 2.0% to $93.56 late Thursday in U.S. trading. The move came with the medical-technology group trading firmer and as traders eyed a planned quarterly dividend from the vascular-device maker. The stock traded in a $92.15 to $95.57 range. Market cap stood around $2.15 billion. LeMaitre's move comes as the company looks to hold investor backing after posting a solid first-quarter report in May. Bigger medical device stocks have seen new buying, too. The iShares U.S. Medical Devices ETF gained 2.8%. That compares to a 0.4% uptick for the SPDR S&P 500 ETF.
June 5, 2026
1st Source Rises on Regional Bank Rally; Eyes on Credit Ahead

1st Source Rises on Regional Bank Rally; Eyes on Credit Ahead

1st Source Corp. climbed 2.7% to $74.65 late Thursday as regional banks bounced. That move put the South Bend, Indiana bank’s market cap near $1.81 billion. Shares changed hands between $73.31 and $74.90, with trading volume at roughly 131,400 shares. Smaller bank stocks have mostly followed the same playbook lately, with investors focusing on funding costs, loan demand and credit losses instead of growth stories. 1st Source moved after its first-quarter numbers, which showed profit up from a year ago, a raised dividend and a higher loan loss reserve.
June 5, 2026
Digital Turbine Gains as Nasdaq Drops — APPS Eyes Launchpad

Digital Turbine Gains as Nasdaq Drops — APPS Eyes Launchpad

Digital Turbine shares moved up late Thursday, bucking a choppy U.S. tech sector. Traders looked to the mobile-software firm’s new app-distribution platform while the company remains lossmaking. The stock on Nasdaq traded up 7.6% at $9.32 in recent action, ranging from $8.33 to $9.45 so far. Around 9.15 million shares changed hands. The company had a market cap close to $1.12 billion.
June 5, 2026
Janux Therapeutics Shares Tick Up, With Focus Staying on Next Trial Update

Janux Therapeutics Shares Tick Up, With Focus Staying on Next Trial Update

Janux Therapeutics shares climbed in late U.S. trading Thursday, finishing the regular Nasdaq session ahead but trailing gains seen across biotech. The stock last traded at $13.76, up 16.5 cents, or roughly 1.2%. It moved between $13.60 and $14.07. The SPDR S&P Biotech ETF climbed 2.7%, while the iShares Nasdaq Biotechnology ETF added 2.3%. Both are ETFs tracking the biotech sector. The Invesco QQQ Trust slipped 0.5%. It tracks bigger Nasdaq growth stocks.
June 5, 2026

BioLife Solutions Shares Edge Lower On Latest SEC Disclosures

BioLife Solutions shares dropped late Thursday in U.S. trading, underperforming other biotech names, after the cell-therapy tools company published a new investor deck and Casdin Capital revealed a big stake. The Nasdaq stock traded at $27.09, off 17 cents, or 0.6%. The SPDR S&P Biotech ETF was up around 2.7%. BioLife Solutions is aiming to steer investors toward a 2026 growth story, after shifting its portfolio to cell processing products. The company, based in Bothell, Washington, filed a June 3 Form 8-K, telling investors the latest presentation could be used at the Jefferies Global Healthcare Conference or in meetings with investors and analysts.
June 5, 2026
Inotiv Stock Slides After Chapter 11 Plan Signals Shareholders at Risk

Inotiv Stock Slides After Chapter 11 Plan Signals Shareholders at Risk

Inotiv Inc. shares dropped further into penny-stock range Thursday. The drug-research services firm rolled out a prepackaged Chapter 11 plan that wipes out existing shareholders, offering them no recovery. The stock last changed hands at 8.66 cents, off roughly 28% from where it closed before. Shares moved in a range from 7.79 cents to 11.8 cents. Volume topped 15 million shares.
June 5, 2026
Playtika Slips Again as Investors Look for a Spark

Playtika Slips Again as Investors Look for a Spark

Playtika Holding Corp. slipped again Thursday, with the mobile-games group under pressure while most of the wider U.S. market was steadier. Shares on the Nasdaq last changed hands at $3.15, down 5 cents, with around 984,000 shares moved. Playtika is betting that strength in newer games and higher direct-to-consumer sales will balance out the slumps in its older franchises. Direct-to-consumer, or DTC, is when players pay straight through the company’s own channel, instead of mostly using app stores.
June 5, 2026
Neonode Shares Rally for Second Straight Day as Traders Eye Next Move

Neonode Shares Rally for Second Straight Day as Traders Eye Next Move

Neonode Inc. shares climbed again Thursday, adding to a midweek surge for the Nasdaq-listed micro-cap. The stock gained while tech shares in general faced pressure. The stock ended the day at $1.85, up 1.65%. Shares changed hands in a range of $1.75 to $1.89. About 125,000 shares traded. Liquidity stayed moderate, which can be an issue for small companies.
June 5, 2026
Alzamend Neuro Shares Dip With AL001 Trial in Focus, Cash Concerns Linger

Alzamend Neuro Shares Dip With AL001 Trial in Focus, Cash Concerns Linger

Alzamend Neuro Inc. shares slipped late Thursday in U.S. trading. The stock trailed gains in other biotech names as investors looked for an upcoming clinical update from the small drug developer and questioned how it will cover funding requirements. The Nasdaq-listed stock was last at $1.14, off 4 cents. Shares moved in a $1.11 to $1.14 range, with about 14,000 shares traded at last check. The SPDR S&P Biotech ETF, which tracks the wider biotech sector, was in the green, which points to the drop being tied to the stock and not the group as a whole.
June 4, 2026
mF International Drops as Nasdaq Deadline Looms

mF International Drops as Nasdaq Deadline Looms

Shares of mF International Limited ended at $9.00 Thursday, off 51 cents, with volume less than 4,000 shares. The Hong Kong trading-tech firm is still facing investor pressure after it delayed its annual report and brought in a new auditor. Timing is important here as mF is in the middle of a Nasdaq compliance clock. The company said on May 21 that Nasdaq told it it was out of compliance with Listing Rule 5250, which says companies have to file periodic reports on time. mF hadn’t filed its Form 20-F for the year ended Dec. 31, 2025. That annual report for foreign private issuers goes to the U.S. Securities and Exchange Commission.
June 4, 2026
MicroAlgo Shares React to Quantum Simulator Update; Volumes Stay Light

MicroAlgo Shares React to Quantum Simulator Update; Volumes Stay Light

MicroAlgo Inc. finished up 1.17% at $5.17 on Nasdaq Thursday after saying it launched a new quantum-algorithm simulation technology. Volume came in at 142,930 shares, well under Google Finance’s average of 850,010. The stock traded in a range from $4.90 to $5.30. U.S. markets traded as usual today. It wasn't a holiday-thinned session. According to Nasdaq’s 2026 calendar, the next closure in June is Juneteenth, June 19. June 4 isn’t on the list of closure dates.
June 4, 2026
Youxin Technology Stock Falls Back Below $1 After YAAS Jump — Why Traders Are Watching Now

Youxin Technology Stock Falls Back Below $1 After YAAS Jump — Why Traders Are Watching Now

Youxin Technology Ltd shares fell back below $1 on Thursday, giving up part of a sharp prior-day move as trading in the Nasdaq-listed China software microcap stayed thin. Google Finance showed the stock closed at $0.94, down 7.84%, before slipping to $0.91 after hours; it listed volume at 98,480 shares and market value at about $10.6 million. That matters because the move reversed part of Wednesday’s jump. Trading 212 data showed Youxin closed at $1.02 on June 3 after a 14.7% gain, then opened at $1.02 on Thursday and fell as low as $0.87.
June 4, 2026
Stratasys Drops After Hours; Focus on Markforged Deal

Stratasys Drops After Hours; Focus on Markforged Deal

Stratasys Ltd. shares dropped roughly 3% late Thursday, as investors questioned if buying Markforged will jump-start growth without stacking up more execution risk for the 3D-printer company. The stock last traded at $9.56, after starting the session at $9.83 and swinging from $9.545 to $9.90. Timing is key. Stratasys is working to move investor focus away from choppy industrial demand and margin concerns, pushing the case for its growth in aerospace, defense, and higher-end 3D printing. The company, which calls the method additive manufacturing, makes parts layer by layer using digital files.
June 4, 2026
1 114 115 116 117 118 492